We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Vaso Stock Up Following Strong Q3 Earnings and Profit Turnaround
Read MoreHide Full Article
Shares of Vaso Corporation (VASO - Free Report) have gained 27.3% since the company reported earnings for the quarter ended Sept. 30, 2025, far outpacing the S&P 500 Index’s 2.2% loss over the same period. Over the past month, Vaso’s shares advanced 19.7%, while the S&P 500 slipped 2%.
VASO’s Earnings Snapshot
In the third quarter of 2025, Vaso delivered solid top-line expansion and a meaningful turnaround in profitability. Total revenue rose 9.1% year over year to $22.7 million from $20.8 million in the prior-year quarter. Net income reached $1.7 million against a net loss of $1.2 million a year earlier, driven by higher revenue, stronger gross margin and reduced operating expenses.
Segment results showed broad-based growth — professional sales service revenue increased 18.7%, IT segment revenue edged up 1.2% and equipment segment revenue grew 8%, supported primarily by higher ARCS software subscription revenue in the United States.
Vaso’s Other Key Business Metrics
Gross profit improved 18.2%, reaching $13.9 million from $11.8 million in the third quarter of 2024. This reflected not only higher revenue but enhanced margins across business segments. Selling, general and administrative expenses increased 7% to $12.2 million from $11.4 million, primarily due to higher personnel costs in the IT and professional sales service divisions, though this was partially offset by lower expenses in the equipment segment.
Adjusted EBITDA — a key non-GAAP metric used by management — was $1.6 million against a loss of $1.2 million in the prior-year quarter. The improvement was attributable to the stronger net income performance. VASO highlighted that subscription revenues continue to represent a significant portion of total revenues, supporting recurring cash generation.
Cash generation remained robust. Vaso reported $2.8 million in operating cash flow during the quarter and $9 million for the first nine months of 2025, up sharply from $3.6 million in the comparable 2024 period. Cash and cash equivalents stood at $34.9 million as of Sept. 30, 2025.
Vaso Corporation Price, Consensus and EPS Surprise
Management emphasized that all three business segments contributed to quarterly revenue growth. The professional sales services division benefited from a higher volume of equipment delivered by its partner, GE HealthCare, underscoring the importance of Vaso’s long-standing exclusive sales representation agreement. In the IT segment, revenue gains were driven by network services despite weaker healthcare IT sales, suggesting resiliency in demand for managed network offerings. Meanwhile, improved subscription revenue in the equipment segment helped offset softness in China-based equipment deliveries.
CEO Dr. Jun Ma highlighted VASO’s strong balance sheet, rising deferred revenue and the sustained momentum in subscription-based income streams. Ma reinforced expectations for continued topline stability and noted the upcoming Annual Shareholders Meeting scheduled for Dec. 17, 2025, in New York City.
Factors Influencing Vaso’s Headline Numbers
The return to profitability was driven by a combination of revenue growth, better product mix and improved margin performance. Higher ARCS software subscription revenue and increased U.S. installations supported profitability in the equipment segment, even as China’s equipment deliveries moderated. In professional sales services, the rise in delivered equipment from GE HealthCare translated directly into double-digit growth.
Operating expenses grew at a slower pace than gross profit, which helped improve operating income to $1.5 million from a loss of $1.4 million last year. Reduced expenses in the equipment segment, along with disciplined cost management companywide, contributed to the margin recovery. Additionally, rising deferred revenue indicates growing commitments for future services, supporting longer-term revenue visibility.
VASO’s Guidance
Vaso did not provide formal financial guidance for future periods. However, management’s commentary pointed to expectations of a stable topline supported by recurring subscription revenues and continued upward momentum in deferred revenue. No specific revenue, earnings or margin targets were issued.
Vaso’s Other Developments
No acquisitions, divestitures or business restructuring initiatives were disclosed by Vaso. Management did not reference any mergers, asset sales or significant organizational changes during the quarter.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Vaso Stock Up Following Strong Q3 Earnings and Profit Turnaround
Shares of Vaso Corporation (VASO - Free Report) have gained 27.3% since the company reported earnings for the quarter ended Sept. 30, 2025, far outpacing the S&P 500 Index’s 2.2% loss over the same period. Over the past month, Vaso’s shares advanced 19.7%, while the S&P 500 slipped 2%.
VASO’s Earnings Snapshot
In the third quarter of 2025, Vaso delivered solid top-line expansion and a meaningful turnaround in profitability. Total revenue rose 9.1% year over year to $22.7 million from $20.8 million in the prior-year quarter. Net income reached $1.7 million against a net loss of $1.2 million a year earlier, driven by higher revenue, stronger gross margin and reduced operating expenses.
Segment results showed broad-based growth — professional sales service revenue increased 18.7%, IT segment revenue edged up 1.2% and equipment segment revenue grew 8%, supported primarily by higher ARCS software subscription revenue in the United States.
Vaso’s Other Key Business Metrics
Gross profit improved 18.2%, reaching $13.9 million from $11.8 million in the third quarter of 2024. This reflected not only higher revenue but enhanced margins across business segments. Selling, general and administrative expenses increased 7% to $12.2 million from $11.4 million, primarily due to higher personnel costs in the IT and professional sales service divisions, though this was partially offset by lower expenses in the equipment segment.
Adjusted EBITDA — a key non-GAAP metric used by management — was $1.6 million against a loss of $1.2 million in the prior-year quarter. The improvement was attributable to the stronger net income performance. VASO highlighted that subscription revenues continue to represent a significant portion of total revenues, supporting recurring cash generation.
Cash generation remained robust. Vaso reported $2.8 million in operating cash flow during the quarter and $9 million for the first nine months of 2025, up sharply from $3.6 million in the comparable 2024 period. Cash and cash equivalents stood at $34.9 million as of Sept. 30, 2025.
Vaso Corporation Price, Consensus and EPS Surprise
Vaso Corporation price-consensus-eps-surprise-chart | Vaso Corporation Quote
VASO’s Management Commentary
Management emphasized that all three business segments contributed to quarterly revenue growth. The professional sales services division benefited from a higher volume of equipment delivered by its partner, GE HealthCare, underscoring the importance of Vaso’s long-standing exclusive sales representation agreement. In the IT segment, revenue gains were driven by network services despite weaker healthcare IT sales, suggesting resiliency in demand for managed network offerings. Meanwhile, improved subscription revenue in the equipment segment helped offset softness in China-based equipment deliveries.
CEO Dr. Jun Ma highlighted VASO’s strong balance sheet, rising deferred revenue and the sustained momentum in subscription-based income streams. Ma reinforced expectations for continued topline stability and noted the upcoming Annual Shareholders Meeting scheduled for Dec. 17, 2025, in New York City.
Factors Influencing Vaso’s Headline Numbers
The return to profitability was driven by a combination of revenue growth, better product mix and improved margin performance. Higher ARCS software subscription revenue and increased U.S. installations supported profitability in the equipment segment, even as China’s equipment deliveries moderated. In professional sales services, the rise in delivered equipment from GE HealthCare translated directly into double-digit growth.
Operating expenses grew at a slower pace than gross profit, which helped improve operating income to $1.5 million from a loss of $1.4 million last year. Reduced expenses in the equipment segment, along with disciplined cost management companywide, contributed to the margin recovery. Additionally, rising deferred revenue indicates growing commitments for future services, supporting longer-term revenue visibility.
VASO’s Guidance
Vaso did not provide formal financial guidance for future periods. However, management’s commentary pointed to expectations of a stable topline supported by recurring subscription revenues and continued upward momentum in deferred revenue. No specific revenue, earnings or margin targets were issued.
Vaso’s Other Developments
No acquisitions, divestitures or business restructuring initiatives were disclosed by Vaso. Management did not reference any mergers, asset sales or significant organizational changes during the quarter.